yahoo_financeOriginal article
Serina Says Panel Clears Dosing More Patients in Phase 1b Trial of SER-252 in Parkinson's Disease
Phase 1positiveSER-252Positive
AI Analysis
Summary
Serina announced that a panel has cleared the dosing of additional patients in the Phase 1b trial of SER-252 for Parkinson's Disease treatment.
Clinical Trial Data
Phase
1b
Outcome Details
Panel cleared dosing more patients in Phase 1b trial
Importance:5/10
Sentiment:
0.60
Phase 1bParkinson's DiseaseClinical TrialSER-252
Related Companies
Read the original article
Published by yahoo_finance on July 9, 2026 4:40 PM